PENNANTPARK INVESTMENT CORP
PNNTAbout the company
PennantPark Investment Corporation, a business development company is a private equity fund specializes in direct and mezzanine investments in middle market companies. It invests in the form of mezzanine debt, senior secured loans, and equity investments.
Investment snapshot
Positive
1
BUY / PASS
Neutral / negative
4 / 11
NEUTRAL / FAIL
Median fair value
$4.38
+39.5% vs price
Models with upside
2 / 17
Positive margin of safety
Strongest signal
PNNT undervalued: all 2 models price fair value above $3.14 (median $4.38)
Key risk
No clean pass — all 8 investors flag at least one growth criterion
Framework analysis
| Verdict | Meaning |
|---|---|
| BUY | Positive purchase signal: the framework's buy requirements are met. |
| PASS | The company clears the framework's checklist or screen, but the framework does not produce a buy signal. For valuation frameworks this often means margin of safety is missing, insufficient, or unavailable; some screen-only frameworks have no intrinsic-value BUY state. |
| NEUTRAL | Neither a positive nor negative conclusion. It does not mean to hold an existing position. |
| FAIL | The company does not clear the framework's requirements. |
| Ranked | Ranked strategies do not use PASS: selected cohort is BUY, outside the cohort is FAIL, and unranked is NEUTRAL. |
Current investor scores use trailing 12-month flows and the latest balance sheet where supported. Multi-year and EPS tests retain annual history; each framework shows its financial basis below. Intrinsic values use annual financials.
| Metric | Graham Defensive Value | Buffett Quality Compounder | Lynch GARP | Greenblatt Magic Formula | Piotroski F-Score | Dreman Contrarian Value | Munger Quality Focus | Pabrai Dhandho Framework | Akre Three-Legged Stool | Marks Risk-Aware Value | Ackman Activist Value | Templeton Global Bargain Hunter | Sleep Scale Economies Shared | Asness Systematic Factors | Neff Low-P/E Total Return | Schloss Asset-Value Discipline | O'Shaughnessy Systematic Factor Composite |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Verdict | FAIL | FAIL | FAIL | Not ranked | PASS | FAIL | FAIL | FAIL | FAIL | FAIL | FAIL | NEUTRAL | FAIL | NEUTRAL | FAIL | NEUTRAL | NEUTRAL |
| Score | |||||||||||||||||
| Analysis | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… |
| Intrinsic Value (annual) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | ||
| Margin of Safety | N/A | N/A | N/A | N/A | N/A | N/A | N/A | +16.3% | +37.3% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Financial Basis | Annual history · FY 2025 Latest source filing: 2025-11-24 Score computed: 2026-11-14 | Annual history · FY 2025 Latest source filing: 2025-11-24 Score computed: 2026-11-14 | Annual history · FY 2025 · Balance sheet at 2026-06-30 · TTM ended 2026-06-30 Latest source filing: 2026-08-10 Score computed: 2026-11-14 | Annual history · FY 2025 Latest source filing: 2025-11-24 Score computed: 2026-11-14 | Annual history · FY 2025 Latest source filing: 2025-11-24 Score computed: 2026-11-14 | Annual history · FY 2025 · TTM ended 2026-06-30 · Balance sheet at 2026-06-30 · Market data at 2026-11-01 Latest source filing: 2026-08-10 Score computed: 2026-11-14 | Qualitative assessment · Annual history · FY 2025 · Balance sheet at 2026-06-30 Latest source filing: 2026-08-10 Score computed: 2026-11-14 | Qualitative assessment · Annual history · FY 2025 Latest source filing: 2025-11-24 Score computed: 2026-11-14 | Annual history · FY 2025 · Qualitative assessment · Balance sheet at 2026-06-30 Latest source filing: 2026-08-10 Score computed: 2026-11-14 | Annual history · FY 2025 · Qualitative assessment Latest source filing: 2025-11-24 Score computed: 2026-11-14 | Annual history · FY 2025 · TTM ended 2026-06-30 · Balance sheet at 2026-06-30 · Market data at 2026-11-01 Latest source filing: 2026-08-10 Score computed: 2026-11-14 | Annual history · FY 2025 · Price history 2025-01-01–2026-11-01 · Balance sheet at 2026-06-30 Latest source filing: 2026-08-10 Score computed: 2026-11-14 | Annual history · FY 2025 · Qualitative assessment Latest source filing: 2025-11-24 Score computed: 2026-11-14 | TTM ended 2026-06-30 · Balance sheet at 2026-06-30 · Price history 2025-01-01–2026-11-01 · Annual history · FY 2025 Latest source filing: 2026-08-10 Score computed: 2026-11-14 | Annual history · FY 2025 Latest source filing: 2025-11-24 Score computed: 2026-11-14 | Annual history · FY 2025 · Balance sheet at 2026-06-30 Latest source filing: 2026-08-10 Score computed: 2026-11-14 | Annual history · FY 2025 · TTM ended 2026-06-30 · Price history 2025-01-01–2026-11-01 Latest source filing: 2026-08-10 Score computed: 2026-11-14 |
Where It Passes
- Valuation models100% pass✓ 2▾
PNNT undervalued: all 2 models price fair value above $3.14 (median $4.38)
Pabrai fair value$3.75✓Pabrai+16.3% margin vs $3.14Akre fair value$5.01✓Akre+37.3% margin vs $3.14
Where It Falls Short
- Growth0% pass✓ 1✗ 12▾
No clean pass — all 8 investors flag at least one growth criterion
EPS Growth (3-yr avg, 10-yr window)✗Graham>= 33% growthBasic earnings-growth PEG (dividends excluded)✗Lynch< 1.0 (ideally < 0.5)3-5 Year EPS CAGR✗Lynch15-30% (Fast Grower); > 0% to passInventory Growth vs Revenue GrowthN/A (no inventory)✓LynchInventory growth < Revenue growthEPS Growth Direction✗DremanPositive over recent yearsEPS CAGR✗Dreman> 5% annualizedPositive Net Income Frequency3/6 years positive✗MarksPositive net income in >= 7 of last 10 years3yr Median Revenue Growth✗Ackman>= 5%Positive EPS Growth Frequency✗AckmanPositive EPS growth in >= 3 of last 5 years5-Year EPS CAGR✗Templeton> 0% (5-year EPS CAGR)Revenue growth vs. gross and operating margin trend✗SleepRevenue rising; gross margin flat or falling; operating margin holding5-year Revenue CAGR✗SleepCAGR > 7%3-5 Year Diluted EPS CAGR✗Neff7%-20% annualized - Efficiency0% pass✗ 11▾
All 8 investors flag PNNT's efficiency
Current Ratio✗Graham>= 2.0ROIC (3-5 yr avg)✗Buffett> 10%ROIC - WACC✗BuffettPositive (WACC = 10%)EBIT / (NWC + Net Fixed Assets)✗Greenblatt> 25%Current Ratio Change YoY✗PiotroskiIncreased YoYRevenue / Total Assets Change YoY✗PiotroskiImproved YoYCurrent Assets / Current Liabilities✗Dreman> 1.5Return on Invested Capital✗Munger> 15%ROIC (high and growing)FY2023: ROIC=unavailable; FY2024: ROIC=unavailable; FY2025: ROIC=unavailable✗AkreLatest 3 consecutive FYs: ROIC > 15% in eachReinvestment Rate x ROIC✗AkreReinvestment Rate * ROIC > 10%ROIC (5-year)✗SleepROIC > 12% in a majority of years - Profitability6% pass✓ 4✗ 31▾
15 of 16 flag PNNT's profitability — Graham, Buffett, Lynch +12 more
Net income / market capitalization+4.94%; #1704/6340 (top 26.9%)✓AsnessTop 30% of eligible cross-section✗OshaughnessyTop 10% of eligible cross-sectionPositive EPS (10 years)0/8 years positive✗GrahamPositive EPS every year for 10 yearsEPS Growth (3-yr avg, 10-yr window)✗Graham>= 33% growthNet Income Positive (10+ years)3/8 years positive✗BuffettPositive every year for 10+ yearsROE (up to 5-year arithmetic mean)6.2%✗Buffett> 15% arithmetic mean (app rule)Operating Margin (10-yr trend)✗BuffettStable or rising over 10 yearsFree Cash Flow Proxy✗BuffettPositive and growingEarnings Variance (10-yr CoV)✗BuffettCoV < 0.3Retained Earnings Effectiveness✗Buffett$1 retained -> > $1 market value createdBasic earnings-growth PEG (dividends excluded)✗Lynch< 1.0 (ideally < 0.5)3-5 Year EPS CAGR✗Lynch15-30% (Fast Grower); > 0% to passROE2.4%✗Lynch> 15%EBIT / Enterprise Value✗Greenblatt> 10%Earnings Yield + ROC AssessmentEY=None, ROC=None✗GreenblattBoth EY > 10% and ROC > 25%Net Income / Total Assets2.42%✓PiotroskiROA > 0ROA Change YoY3.52% -> 2.42% (delta: -1.09%)✗PiotroskiCurrent ROA > Prior ROA(CFO / Total Assets) vs ROACFO/Assets=7.76%, ROA=2.42%✓PiotroskiCFO/Assets > ROAGross Margin Change YoY✗PiotroskiImproved YoYPre-Tax Income / Revenue✗Dreman>= 8%Net Income / Shareholders' Equity2.4%✗Dreman> 12%Margin of SafetyP/B=0.4x✓PabraiP/B < 1.5 or P/E < 15Return on Equity3.4% (3-yr avg)✗AkreROE > 20% (3-year avg)Discount to Intrinsic Value✗Marks>= 20% below intrinsic valuePositive Net Income Frequency3/6 years positive✗MarksPositive net income in >= 7 of last 10 yearsOperating Income / Revenue✗Ackman>= 15%Net Income / Shareholders Equity2.4%✗Ackman>= 15%5-Year EPS CAGR✗Templeton> 0% (5-year EPS CAGR)Operating Margin Trend✗TempletonNon-negative operating-margin trend over 3 yearsRevenue growth vs. gross and operating margin trend✗SleepRevenue rising; gross margin flat or falling; operating margin holdingGross profit / total assets✗AsnessTop 30% of eligible cross-sectionNet income / positive book equity+2.37%; #2725/5226 (top 52.1%)✗AsnessTop 30% of eligible cross-sectionNegative 5-year standard deviation of ROA-0.0560; #2717/5884 (top 46.2%)✗AsnessTop 30% of eligible cross-section3-5 Year Diluted EPS CAGR✗Neff7%-20% annualizedPositive Diluted-EPS Years✗Schloss>= 70% positive over 5-10 observed years (app rule) - Valuation8% pass✓ 10✗ 18▾
12 of 13 flag PNNT's valuation — Graham, Lynch, Greenblatt +9 more
Net income / market capitalization+4.94%; #1704/6340 (top 26.9%)✓AsnessTop 30% of eligible cross-section✗OshaughnessyTop 10% of eligible cross-sectionPrice / 3-yr avg EPS✗Graham<= 15xPrice-to-Book Ratio0.4x✓Graham<= 1.5xP/E x P/B✗Graham<= 22.5Basic earnings-growth PEG (dividends excluded)✗Lynch< 1.0 (ideally < 0.5)EBIT / Enterprise Value✗Greenblatt> 10%Earnings Yield + ROC AssessmentEY=None, ROC=None✗GreenblattBoth EY > 10% and ROC > 25%Price / EPS✗Dreman< 12x✗Templeton< 12x (fixed ceiling; proxy for the market's cheapest 40%)Price / (CFO / Shares)2.0x✓Dreman< 8xPrice / Book Value per Share0.4x✓Dreman< 1.2x✓Templeton< 1.5x✓SchlossP/B <= 0.80x (app cutoff)Valuation Reasonableness✗MungerP/E < 25 or Owner Earnings Yield > 5%P/E or FCF Yield✗PabraiP/E < 15 or FCF Yield > 10%P/B or P/E vs. Historical AverageP/B=0.4x✓MarksP/E < 15 or P/B < 2.0Discount to Intrinsic Value✗Marks>= 20% below intrinsic valuePrice / FCF per Share✗Ackman<= 25Price vs. Trailing Low104% of trailing low ($3.02)✓Templeton<= 120% of trailing low (certified split-adjusted live window)Positive book equity / market capitalization+2.0877; #651/6449 (top 10.1%)✓AsnessTop 30% of eligible cross-sectionPrice / Diluted EPS✗NeffP/E <= 15x (app proxy for a P/E 40%-60% below the market)(EPS CAGR % + Dividend Yield %) / P/E✗Neff> 0.7 (Neff's published traditional edge)Price / Tangible Book Value per Share0.44x✓SchlossP/TBV <= 1.00x (app cutoff)Book Value per Share Change-9.4%✗SchlossLatest BVPS >= earliest BVPS over >= 3 years (app rule)Revenue / market capitalization✗OshaughnessyTop 10% of eligible cross-section(Operating cash flow - capex) / market capitalization✗OshaughnessyTop 10% of eligible cross-sectionTrailing six-month price return through the evaluation date-29.60%; #4409/6202 (top 71.1%)✗OshaughnessyTop 10% of eligible cross-section - Verdicts8% pass✓ 1✗ 11▾
Split decision: 11 FAIL · 4 NEUTRAL · 1 PASS
Overall verdict✗GrahamFAIL (1/9)✗BuffettFAIL (0/9)✗LynchFAIL (1/7)•GreenblattNot ranked✓PiotroskiPASS (F-Score 5)✗DremanFAIL (4/11)✗MungerFAIL (1/4)✗PabraiFAIL (1/3)✗AkreFAIL (0/6)✗MarksFAIL (1/5)✗AckmanFAIL (1/9)•TempletonNEUTRAL (5/8)✗SleepFAIL (1/6)•AsnessNEUTRAL (Not ranked)✗NeffFAIL (1/6)•SchlossNEUTRAL (4/7)•OshaughnessyNEUTRAL (Not ranked) - Cash Flow20% pass✓ 3✗ 9▾
8 of 10 flag PNNT's cash flow — Buffett, Lynch, Pabrai +5 more
Free Cash Flow Proxy✗BuffettPositive and growingFCF Positive and Growing✗LynchPositive and growingOperating Cash Flow$104.8M✓PiotroskiCFO > 0(CFO / Total Assets) vs ROACFO/Assets=7.76%, ROA=2.42%✓PiotroskiCFO/Assets > ROAPrice / (CFO / Shares)2.0x✓Dreman< 8xP/E or FCF Yield✗PabraiP/E < 15 or FCF Yield > 10%FCF Positive✗MarksPositive FCF in majority of recent years(OCF - CapEx) / Market Cap✗Ackman>= 4%Price / FCF per Share✗Ackman<= 25Positive Operating Cash Flow frequency3/6 years positive✗SleepPositive OCF in >= 70% of available yearsOperating Cash Flow - Capital Expenditures✗Neff> $0 (app proxy for a strong fundamental case)(Operating cash flow - capex) / market capitalization✗OshaughnessyTop 10% of eligible cross-section - Debt & Leverage25% pass✓ 5✗ 10▾
9 of 12 flag PNNT's debt & leverage — Graham, Buffett, Lynch +6 more
LT Debt vs Net Current Assets✗GrahamLT Debt <= Net Current AssetsDebt/Equity & Interest CoverageD/E: 0.92, IC: N/A✗BuffettD/E < 0.5 AND Interest Coverage > 5xTotal Debt / Equity0.72✗Lynch< 0.33Cash - Long-term Debt✗LynchPositive preferredLT Debt / Total Assets Change0.00% -> 0.00%✓PiotroskiDecreased YoYCurrent Assets / Current Liabilities✗Dreman> 1.5✗SchlossCurrent ratio >= 1.50x (app cutoff)Total Debt / Shareholders' Equity0.72✓Dreman< 0.8✓Templeton< 1.0 (fixed cap; proxy for below-sector-median leverage)✓SchlossD/E < 1.00xDebt Levels0.72✗MungerDebt/Equity < 0.5✗AkreDebt/Equity < 0.3Interest Coverage & Debt/EBITDA✗MarksInterest Coverage > 3x; Debt/EBITDA < 4xTotal Debt / Shareholders Equity0.72✓Ackman<= 1.0Negative debt-to-equity (higher means less debt)-0.7237; #2882/4210 (top 68.5%)✗AsnessTop 30% of eligible cross-section
Business & financials
Financial snapshot: annual FY 2025. Current investor scores may use newer quarterly data.
Company Profile
Financial Snapshot
Similar Companies
No peer companies found in this industry.
Shareholder Return
Fiscal 2025
Retired 0.0% of shares last year, 0.1% issued over two.
- Buybacks
- —
- Dividends
- $67.9M
Company Financials
Latest TTM and quarters alongside annual years
TTM sums four consecutive quarters and uses the latest quarter-end balances. Quarter columns show three-month results; annual columns show full-year totals. Growth compares the same period a year earlier. EPS is not added for TTM; full-year ratios are blank for quarters.
The latest annual period end is unavailable. Showing the latest fiscal cycle’s quarters; quarter and annual columns may overlap. Quarterly shows the full quarter history.
| Metric | TTM · 2026-06-30 2025-07-01 – 2026-06-30 Sources · derived quarter valuesDerived from cumulative filings: net income, operating cash flow, dividends paid. | Q3 FY 2026 2026-04-01 – 2026-06-30 Sources · derived quarter valuesDerived from cumulative filings: operating cash flow, dividends paid. | Q2 FY 2026 2026-01-01 – 2026-03-31 Sources · derived quarter valuesDerived from cumulative filings: operating cash flow, dividends paid. | Q1 · 2025-12-31 2025-10-01 – 2025-12-31 Sources | FY 2025Sources
| FY 2024Sources
| FY 2023Sources
| FY 2022Sources
| FY 2021Sources
|
|---|---|---|---|---|---|---|---|---|---|
| Market Cap | $205.0Mcurrent | -- | -- | -- | $363.6Mest. | $384.6Mest. | $334.4Mest. | $247.1Mest. | $273.4Mest. |
| Revenue | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Operating Income | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Net Income | $10.1M↓81% | $4.5M↓45% | -$2.3M↓125% | $9.0M↓44% | $32.7M↓33% | $48.9M↑244% | -$33.8M↓37% | -$24.7M↓115% | $166.6M |
| EPS (Diluted) | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Gross Margin | — | — | — | — | — | — | — | — | — |
| Operating Margin | — | — | — | — | — | — | — | — | — |
| ROE | 2.4%↓78% | — | — | — | 7.1%↓29% | 9.9%↑247% | -6.7%↓59% | -4.2%↓117% | 25.2% |
| Total Debt | $309.8M↓2% | $309.8M↓2% | $199.5M↓36% | $295.5M↓36% | $425.5M↓8% | $460.4M↑122% | $206.9M↓45% | $376.7M↑20% | $314.8M |
| Shareholders' Equity | $428.0M↓11% | $428.0M↓11% | $439.2M↓10% | $457.2M↓8% | $463.9M↓6% | $493.9M↓2% | $502.2M↓14% | $585.6M↓11% | $660.1M |
| Current Ratio | — | — | — | — | — | — | — | — | — |
| Debt / Equity | 0.72↑10% | 0.72↑10% | 0.45↓29% | 0.65↓31% | 0.92↓2% | 0.93↑126% | 0.41↓36% | 0.64↑35% | 0.48 |
| Operating Cash Flow | $113.2M↓46% | $50.1M↓3% | $36.4M↓74% | $134.5M↑618% | $104.8M↑161% | -$172.4M↓177% | $222.9M↑1389% | -$17.3M↓319% | $7.9M |
| Free Cash Flow | -- | -- | -- | -- | -- | -- | -- | -- | -- |